HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Experiences with oxytetracycline treatment of non-gonorrhea urethritis caused by Ureaplasma urealyticum]

AbstractIn a retrospective study, the efficacy of tetracycline therapy was assessed in 48 men with non-gonococcal urethritis who only harbored Ureaplasma urealyticum in their urethras. After 2 weeks of therapy with 2.0 g oxytetracycline per day, U. urealyticum was still found in the urethra of 8 patients (17%). Urethritis was still present in 8 patients (17%) according to clinical criteria and in 11 patients (23%) according to microscopic findings. The persistence of U. urealyticum in the urethra did not correlate with the persistence of urethritis to a statistically significant degree. Therapy compliance, antibiotic resistance in a few cases, reinfections in 2 cases and a special host-parasite relationship are discussed with respect to the treatment failures.
AuthorsP Elsner, A A Hartmann, G Burg (Affiliation: Klinik und Poliklinik für Haut- und Geschlechtskrankheiten, Julius-Maximilians-Universität Würzburg.)
JournalDer Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete (Hautarzt) Vol. 41 Issue 2 Pg. 94-7 (Feb 1990) ISSN: 0017-8470 [Print] GERMANY, WEST
Vernacular TitleErfahrungen mit der Oxytetrazyklin-Therapie der nicht-gonorrhoischen Urethritis durch Ureaplasma urealyticum.
PMID2318645 (Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Oxytetracycline
Topics
  • Adolescent
  • Adult
  • Humans
  • Male
  • Middle Aged
  • Mycoplasmatales Infections (drug therapy, microbiology)
  • Oxytetracycline (administration & dosage)
  • Retrospective Studies
  • Ureaplasma (drug effects, isolation & purification)
  • Urethritis (drug therapy, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD